Global Immuno-Oncology Market Research Report 2025(Status and Outlook)

March 2025 | 209 pages | ID: G36508D2A7CFEN
Bosson Research

Abstracts

Report Overview

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

This report provides a deep insight into the global Immuno-Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-Oncology market in any manner.

Global Immuno-Oncology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bristol-Myers Squibb

Merck & Co.

Inc.

Roche AG

AstraZeneca

Plc

Sanofi S.A.

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc.

Merck KGaA

Market Segmentation (by Type)

Immune Checkpoint Inhibitors

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy

Others

Market Segmentation (by Application)

Hospitals

Drugstores

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Immuno-Oncology Market
• Overview of the regional outlook of the Immuno-Oncology Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-Oncology Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-Oncology
1.2 Key Market Segments
1.2.1 Immuno-Oncology Segment by Type
1.2.2 Immuno-Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Immuno-Oncology Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-Oncology Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Immuno-Oncology Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Immuno-Oncology Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Immuno-Oncology Product Life Cycle
3.3 Global Immuno-Oncology Sales by Manufacturers (2020-2025)
3.4 Global Immuno-Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immuno-Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Immuno-Oncology Manufacturing Sites, Area Served, Product Type
3.8 Immuno-Oncology Market Competitive Situation and Trends
3.8.1 Immuno-Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immuno-Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Immuno-Oncology Industry Chain Analysis
4.1 Immuno-Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-Oncology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immuno-Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Immuno-Oncology Market
5.7 ESG Ratings of Leading Companies
6 Global Immuno-Oncology Market by Region
6.1 Global Immuno-Oncology Market Size by Region
6.1.1 Global Immuno-Oncology Market Size by Region
6.1.2 Global Immuno-Oncology Market Size Market Share by Region
6.2 Global Immuno-Oncology Sales by Region
6.2.1 Global Immuno-Oncology Sales by Region
6.2.2 Global Immuno-Oncology Sales Market Share by Region
7 North America Market Overview
7.1 North America Immuno-Oncology Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Immuno-Oncology Market Size by Type
7.3 North America Immuno-Oncology Market Size by Application
8 Europe Market Overview
8.1 Europe Immuno-Oncology Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Immuno-Oncology Market Size by Type
8.3 Europe Immuno-Oncology Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Immuno-Oncology Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Immuno-Oncology Market Size by Type
9.3 Asia-Pacific Immuno-Oncology Market Size by Application
10 South America Market Overview
10.1 South America Immuno-Oncology Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Immuno-Oncology Market Size by Type
10.3 South America Immuno-Oncology Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Immuno-Oncology Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Immuno-Oncology Market Size by Type
11.3 Middle East and Africa Immuno-Oncology Market Size by Application
12 Immuno-Oncology Market Production by Region
12.1 Global Production of Immuno-Oncology by Region(2020-2025)
12.2 Global Immuno-Oncology Revenue Market Share by Region (2020-2025)
12.3 Global Immuno-Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Immuno-Oncology Production
12.4.1 North America Immuno-Oncology Production Growth Rate (2020-2025)
12.4.2 North America Immuno-Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Immuno-Oncology Production
12.5.1 Europe Immuno-Oncology Production Growth Rate (2020-2025)
12.5.2 Europe Immuno-Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Immuno-Oncology Production (2020-2025)
12.6.1 Japan Immuno-Oncology Production Growth Rate (2020-2025)
12.6.2 Japan Immuno-Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Immuno-Oncology Production (2020-2025)
12.7.1 China Immuno-Oncology Production Growth Rate (2020-2025)
12.7.2 China Immuno-Oncology Production, Revenue, Price and Gross Margin (2020-2025)
13 Immuno-Oncology Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Immuno-Oncology Sales Market Share by Type (2020-2033)
13.3 Global Immuno-Oncology Market Size Market Share by Type (2020-2033)
13.4 Global Immuno-Oncology Price by Type (2020-2033)
14 Immuno-Oncology Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Immuno-Oncology Market Sales by Application (2020-2033)
14.3 Global Immuno-Oncology Market Size (M USD) by Application (2020-2033)
14.4 Global Immuno-Oncology Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Bristol-Myers Squibb
15.1.1 Bristol-Myers Squibb Basic Information
15.1.2 Bristol-Myers Squibb Immuno-Oncology Product Overview
15.1.3 Bristol-Myers Squibb Immuno-Oncology Product Market Performance
15.1.4 Bristol-Myers Squibb Business Overview
15.1.5 Bristol-Myers Squibb SWOT Analysis
15.1.6 Bristol-Myers Squibb Recent Developments
15.2 Merck and Co.
15.2.1 Merck and Co. Basic Information
15.2.2 Merck and Co. Immuno-Oncology Product Overview
15.2.3 Merck and Co. Immuno-Oncology Product Market Performance
15.2.4 Merck and Co. Business Overview
15.2.5 Merck and Co. SWOT Analysis
15.2.6 Merck and Co. Recent Developments
15.3 Inc.
15.3.1 Inc. Basic Information
15.3.2 Inc. Immuno-Oncology Product Overview
15.3.3 Inc. Immuno-Oncology Product Market Performance
15.3.4 Inc. Business Overview
15.3.5 Inc. SWOT Analysis
15.3.6 Inc. Recent Developments
15.4 Roche AG
15.4.1 Roche AG Basic Information
15.4.2 Roche AG Immuno-Oncology Product Overview
15.4.3 Roche AG Immuno-Oncology Product Market Performance
15.4.4 Roche AG Business Overview
15.4.5 Roche AG Recent Developments
15.5 AstraZeneca
15.5.1 AstraZeneca Basic Information
15.5.2 AstraZeneca Immuno-Oncology Product Overview
15.5.3 AstraZeneca Immuno-Oncology Product Market Performance
15.5.4 AstraZeneca Business Overview
15.5.5 AstraZeneca Recent Developments
15.6 Plc
15.6.1 Plc Basic Information
15.6.2 Plc Immuno-Oncology Product Overview
15.6.3 Plc Immuno-Oncology Product Market Performance
15.6.4 Plc Business Overview
15.6.5 Plc Recent Developments
15.7 Sanofi S.A.
15.7.1 Sanofi S.A. Basic Information
15.7.2 Sanofi S.A. Immuno-Oncology Product Overview
15.7.3 Sanofi S.A. Immuno-Oncology Product Market Performance
15.7.4 Sanofi S.A. Business Overview
15.7.5 Sanofi S.A. Recent Developments
15.8 Dendreon Pharmaceuticals
15.8.1 Dendreon Pharmaceuticals Basic Information
15.8.2 Dendreon Pharmaceuticals Immuno-Oncology Product Overview
15.8.3 Dendreon Pharmaceuticals Immuno-Oncology Product Market Performance
15.8.4 Dendreon Pharmaceuticals Business Overview
15.8.5 Dendreon Pharmaceuticals Recent Developments
15.9 Novartis
15.9.1 Novartis Basic Information
15.9.2 Novartis Immuno-Oncology Product Overview
15.9.3 Novartis Immuno-Oncology Product Market Performance
15.9.4 Novartis Business Overview
15.9.5 Novartis Recent Developments
15.10 Gilead Sciences Inc.
15.10.1 Gilead Sciences Inc. Basic Information
15.10.2 Gilead Sciences Inc. Immuno-Oncology Product Overview
15.10.3 Gilead Sciences Inc. Immuno-Oncology Product Market Performance
15.10.4 Gilead Sciences Inc. Business Overview
15.10.5 Gilead Sciences Inc. Recent Developments
15.11 Merck KGaA
15.11.1 Merck KGaA Basic Information
15.11.2 Merck KGaA Immuno-Oncology Product Overview
15.11.3 Merck KGaA Immuno-Oncology Product Market Performance
15.11.4 Merck KGaA Business Overview
15.11.5 Merck KGaA Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Immuno-Oncology Market Size by Type (M USD)
Table 4. Global Immuno-Oncology Market Size by Application (M USD)
Table 5. Immuno-Oncology Market Size Comparison by Region (M USD)
Table 6. Global Immuno-Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Immuno-Oncology Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Immuno-Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Immuno-Oncology Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2024)
Table 11. Global Market Immuno-Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Immuno-Oncology Manufacturing Sites and Area Served
Table 13. Manufacturers Immuno-Oncology Product Type
Table 14. Global Immuno-Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-Oncology Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Immuno-Oncology Market Size Comparison by Region (M USD)
Table 26. Global Immuno-Oncology Market Size by Region (2020-2033) & (M USD)
Table 27. Global Immuno-Oncology Market Size Market Share by Region (2020-2033)
Table 28. Global Immuno-Oncology Sales by Region (2020-2033) & (K Units)
Table 29. Global Immuno-Oncology Sales Market Share by Region (2020-2033)
Table 30. North America Immuno-Oncology Market Size by Country (2020-2033) & (M USD)
Table 31. North America Immuno-Oncology Sales by Country (2020-2033) & (K Units)
Table 32. North America Immuno-Oncology Sales by Type (K Units)
Table 33. North America Immuno-Oncology Market Size by Type (M USD)
Table 34. North America Immuno-Oncology Sales (K Units) by Type (2020-2033)
Table 35. North America Immuno-Oncology Market Size (M USD) by Type (2020-2033)
Table 36. North America Immuno-Oncology Sales by Application (K Units)
Table 37. North America Immuno-Oncology Market Size by Application (M USD)
Table 38. North America Immuno-Oncology Sales (K Units) by Application (2020-2033)
Table 39. North America Immuno-Oncology Market Size (M USD) by Application (2020-2033)
Table 40. Europe Immuno-Oncology Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Immuno-Oncology Sales by Country (2020-2033) & (K Units)
Table 42. Europe Immuno-Oncology Sales by Type (K Units)
Table 43. Europe Immuno-Oncology Market Size by Type (M USD)
Table 44. Europe Immuno-Oncology Sales (K Units) by Type (2020-2033)
Table 45. Europe Immuno-Oncology Market Size (M USD) by Type (2020-2033)
Table 46. Europe Immuno-Oncology Sales by Application (K Units)
Table 47. Europe Immuno-Oncology Market Size by Application (M USD)
Table 48. Europe Immuno-Oncology Sales (K Units) by Application (2020-2033)
Table 49. Europe Immuno-Oncology Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Immuno-Oncology Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Immuno-Oncology Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Immuno-Oncology Sales by Type (K Units)
Table 53. Asia-Pacific Immuno-Oncology Market Size by Type (M USD)
Table 54. Asia-Pacific Immuno-Oncology Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Immuno-Oncology Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Immuno-Oncology Sales by Application (K Units)
Table 57. Asia-Pacific Immuno-Oncology Market Size by Application (M USD)
Table 58. Asia-Pacific Immuno-Oncology Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Immuno-Oncology Market Size (M USD) by Application (2020-2025)
Table 60. South America Immuno-Oncology Market Size by Country (2020-2033) & (M USD)
Table 61. South America Immuno-Oncology Sales by Country (2020-2033) & (K Units)
Table 62. South America Immuno-Oncology Sales by Type (K Units)
Table 63. South America Immuno-Oncology Market Size by Type (M USD)
Table 64. South America Immuno-Oncology Sales (K Units) by Type (2020-2033)
Table 65. South America Immuno-Oncology Market Size (M USD) by Type (2020-2033)
Table 66. South America Immuno-Oncology Sales by Application (K Units)
Table 67. South America Immuno-Oncology Market Size by Application (M USD)
Table 68. South America Immuno-Oncology Sales (K Units) by Application (2020-2033)
Table 69. South America Immuno-Oncology Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Immuno-Oncology Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Immuno-Oncology Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Immuno-Oncology Sales by Type (K Units)
Table 73. Middle East and Africa Immuno-Oncology Market Size by Type (M USD)
Table 74. Middle East and Africa Immuno-Oncology Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Immuno-Oncology Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Immuno-Oncology Sales by Application (K Units)
Table 77. Middle East and Africa Immuno-Oncology Market Size by Application (M USD)
Table 78. Middle East and Africa Immuno-Oncology Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Immuno-Oncology Market Size (M USD) by Application (2020-2033)
Table 80. Global Immuno-Oncology Production (K Units) by Region(2020-2025)
Table 81. Global Immuno-Oncology Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Immuno-Oncology Revenue Market Share by Region (2020-2025)
Table 83. Global Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Immuno-Oncology Sales by Type (K Units)
Table 89. Global Immuno-Oncology Market Size by Type (M USD)
Table 90. Global Immuno-Oncology Sales (K Units) by Type (2020-2033)
Table 91. Global Immuno-Oncology Sales Market Share by Type (2020-2033)
Table 92. Global Immuno-Oncology Market Size (M USD) by Type (2020-2033)
Table 93. Global Immuno-Oncology Market Size Share by Type (2020-2033)
Table 94. Global Immuno-Oncology Sales (K Units) by Application
Table 95. Global Immuno-Oncology Market Size by Application(M USD)
Table 96. Global Immuno-Oncology Sales by Application (2020-2033) & (K Units)
Table 97. Global Immuno-Oncology Sales Market Share by Application (2020-2033)
Table 98. Global Immuno-Oncology Market Size by Application (2020-2033) & (M USD)
Table 99. Global Immuno-Oncology Market Share by Application (2020-2033)
Table 100. Global Immuno-Oncology Sales Growth Rate by Application (2020-2033)
Table 101. Bristol-Myers Squibb Basic Information
Table 102. Bristol-Myers Squibb Immuno-Oncology Product Overview
Table 103. Bristol-Myers Squibb Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Bristol-Myers Squibb Business Overview
Table 105. Bristol-Myers Squibb SWOT Analysis
Table 106. Bristol-Myers Squibb Recent Developments
Table 107. Merck and Co. Basic Information
Table 108. Merck and Co. Immuno-Oncology Product Overview
Table 109. Merck and Co. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Merck and Co. Business Overview
Table 111. Merck and Co. SWOT Analysis
Table 112. Merck and Co. Recent Developments
Table 113. Inc. Basic Information
Table 114. Inc. Immuno-Oncology Product Overview
Table 115. Inc. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Inc. Business Overview
Table 117. Inc. SWOT Analysis
Table 118. Inc. Recent Developments
Table 119. Roche AG Basic Information
Table 120. Roche AG Immuno-Oncology Product Overview
Table 121. Roche AG Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Roche AG Business Overview
Table 123. Roche AG Recent Developments
Table 124. AstraZeneca Basic Information
Table 125. AstraZeneca Immuno-Oncology Product Overview
Table 126. AstraZeneca Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Recent Developments
Table 129. Plc Basic Information
Table 130. Plc Immuno-Oncology Product Overview
Table 131. Plc Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Plc Business Overview
Table 133. Plc Recent Developments
Table 134. Sanofi S.A. Basic Information
Table 135. Sanofi S.A. Immuno-Oncology Product Overview
Table 136. Sanofi S.A. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Sanofi S.A. Business Overview
Table 138. Sanofi S.A. Recent Developments
Table 139. Dendreon Pharmaceuticals Basic Information
Table 140. Dendreon Pharmaceuticals Immuno-Oncology Product Overview
Table 141. Dendreon Pharmaceuticals Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Dendreon Pharmaceuticals Business Overview
Table 143. Dendreon Pharmaceuticals Recent Developments
Table 144. Novartis Basic Information
Table 145. Novartis Immuno-Oncology Product Overview
Table 146. Novartis Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Novartis Business Overview
Table 148. Novartis Recent Developments
Table 149. Gilead Sciences Inc. Basic Information
Table 150. Gilead Sciences Inc. Immuno-Oncology Product Overview
Table 151. Gilead Sciences Inc. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Gilead Sciences Inc. Business Overview
Table 153. Gilead Sciences Inc. Recent Developments
Table 154. Merck KGaA Basic Information
Table 155. Merck KGaA Immuno-Oncology Product Overview
Table 156. Merck KGaA Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Merck KGaA Business Overview
Table 158. Merck KGaA Recent Developments
List of Figures
Figure 1. Product Picture of Immuno-Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-Oncology Market Size (M USD), 2024-2033
Figure 5. Global Immuno-Oncology Market Size (M USD) (2020-2033)
Figure 6. Global Immuno-Oncology Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immuno-Oncology Product Life Cycle
Figure 13. Immuno-Oncology Sales Share by Manufacturers in 2024
Figure 14. Global Immuno-Oncology Revenue Share by Manufacturers in 2024
Figure 15. Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Immuno-Oncology Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immuno-Oncology Revenue in 2024
Figure 18. Industry Chain Map of Immuno-Oncology
Figure 19. Global Immuno-Oncology Market PEST Analysis
Figure 20. Global Immuno-Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Immuno-Oncology Market Size by Region
Figure 27. Global Immuno-Oncology Market Size Market Share by Region (2020-2033)
Figure 28. Global Immuno-Oncology Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Immuno-Oncology Market Size (M USD) by Country
Figure 33. USA Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Immuno-Oncology Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Immuno-Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Immuno-Oncology Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Immuno-Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Immuno-Oncology Market Size (M USD)by Type
Figure 40. North America Immuno-Oncology Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Immuno-Oncology Market Size (M USD) by Country
Figure 45. Germany Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Immuno-Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Immuno-Oncology Market Size (M USD) by Type
Figure 56. Europe Immuno-Oncology Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Immuno-Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Immuno-Oncology Market Size (M USD) by Country
Figure 61. China Immuno-Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Immuno-Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Immuno-Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Immuno-Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Immuno-Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Immuno-Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Immuno-Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Immuno-Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Immuno-Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Immuno-Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Immuno-Oncology Market Size (M USD) by Type
Figure 72. Asia-Pacific Immuno-Oncology Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Immuno-Oncology Market Size (M USD) by Country
Figure 77. Brazil Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Immuno-Oncology Market Size (M USD) by Type
Figure 84. South America Immuno-Oncology Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Immuno-Oncology Market Size (M USD) by Country
Figure 89. Saudi Arabia Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Immuno-Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Immuno-Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Immuno-Oncology Market Size (M USD) by Type
Figure 100. Middle East and Africa Immuno-Oncology Market Size (M USD) by Application
Figure 101. Global Immuno-Oncology Production Market Share by Region (2020-2025)
Figure 102. North America Immuno-Oncology Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Immuno-Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Immuno-Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. China Immuno-Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Immuno-Oncology Market Size by Type (M USD)
Figure 108. Sales Market Share of Immuno-Oncology by Type (2020-2033)
Figure 109. Sales Market Share of Immuno-Oncology by Type in 2024
Figure 110. Market Size Share of Immuno-Oncology by Type (2020-2033)
Figure 111. Market Size Share of Immuno-Oncology by Type in 2024
Figure 112. Global Immuno-Oncology Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Immuno-Oncology Market Size by Application(M USD)
Figure 115. Global Immuno-Oncology Market Share by Application
Figure 116. Global Immuno-Oncology Sales Market Share by Application (2020-2033)
Figure 117. Global Immuno-Oncology Sales Market Share by Application in 2024
Figure 118. Global Immuno-Oncology Market Share by Application (2020-2033)
Figure 119. Global Immuno-Oncology Market Share by Application in 2024
Figure 120. Global Immuno-Oncology Sales Growth Rate by Application (2020-2033)